Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
flu vaccine
Biotech
GSK's mRNA flu vaccine finally bests tricky B strains in phase 2
After an initial defeat against the biggest barrier to mRNA flu vaccines, GSK has returned with a reformulated candidate that has delivered the goods.
James Waldron
Sep 12, 2024 4:52am
Sanofi will drop dwarfism drug as part of rare disease clear-out
Jul 25, 2024 7:58am
CureVac, chasing Moderna mRNA flu shot, hits similar problems
Apr 4, 2024 9:30am
Would you eat a lollipop without candy? The flu virus won't
Jan 16, 2024 9:02am
First-gen mRNA flu vaccines 'will not win,' Sanofi execs admit
Jun 30, 2023 9:10am
Racing Moderna, Pfizer starts phase 3 trial of mRNA flu vaccine
Sep 14, 2022 9:05am
